OnKure Therapeutics, Inc. (OKUR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $113.27M
Last updated: Nov 17, 2026 at 4:10 PM ET
OnKure Therapeutics, Inc. (OKUR) Statistics
OnKure Therapeutics (OKUR) has a market cap of $113.27M. Its share count is up 268.99% from a year earlier. It holds $151.44M more cash than debt, 133.70% of its market cap.
Total Valuation
| Market Cap | $113.27M |
|---|---|
| Latest price (Nov 17, 2026) | $2.58 |
Key Dates
The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| Forward P/S | 906.2x |
|---|---|
| P/B Ratio | 0.8x |
Price Statistics
The stock is down 17.57% over 52 weeks and trades 4.44% below its 50-day average.
| Beta (1Y) | 1.25 |
|---|---|
| 52-Week Change | -17.57% |
| 1-Month Change | +14.67% |
| 3-Month Change | -36.76% |
| 6-Month Change | -21.82% |
| Total Return (1Y) | -17.57% |
| Return vs SPY (1Y) | -23.50% |
| Max Drawdown (1Y) | -60.15% |
| Max Drawdown (3Y) | -90.47% |
| Sharpe Ratio (1Y) | -0.18 |
| Correlation with SPY (1Y) | 0.24 |
| 50-Day Average | $2.70 |
| 200-Day Average | $3.61 |
| 52-Week Range | $2.01 to $5.38 |
| RSI (14 Days) | 45.7 |
| Average Volume (20 Days) | 409.07K |
Financial Position
Current assets cover 18.84x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 18.84x |
|---|---|
| Quick Ratio | 18.84x |
| Debt / Equity | 0.00x |
| Interest Coverage | 15.95x |
Returns and Efficiency
Return on equity is -39.21% and return on assets is -37.02% over the last 12 months.
| Return on Equity (ROE) | -39.21% |
|---|---|
| Return on Assets (ROA) | -37.02% |
| ROA (5Y Average) | -62.86% |
| ROIC (5Y Average) | -88.51% |
Scores
OKUR has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$202.00K |
| Operating Income | -$65.99M |
| Pretax Income | -$61.85M |
| Net Income | -$61.85M |
| Reported EPS (TTM) | -$2.77 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 94.41% of the $167.08M in total assets.
| Cash and Equivalents | $151.44M |
|---|---|
| Total Debt | $0 |
| Net Cash | $151.44M |
| Net Cash Per Share | $3.03 |
| Working Capital | $156.80M |
| Shareholder Equity | $157.74M |
| Book Value Per Share | $3.16 |
| Total Assets | $167.08M |
| Total Liabilities | $9.34M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $49.00K of capital spending, operating cash flow left -$47.94M of free cash flow.
| Operating Cash Flow | -$47.89M |
|---|---|
| Capital Expenditures | $49.00K |
| Free Cash Flow | -$47.94M |
| FCF Per Share | -$1.18 |
| Depreciation and Amortization | $737.00K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
OKUR does not pay a dividend. Its free cash flow yield is -37.21%.
| FCF Yield | -37.21% |
|---|---|
| Buyback Yield | -116.79% |
| Shareholder Yield | -116.79% |
Stock Splits
The last split was a 1-for-10 reverse split on Oct 7, 2024.
| Last Split Date | Oct 7, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About OKUR
What is OKUR's market cap?
OnKure Therapeutics has a market cap of $113.27M.
How many shares of OKUR are outstanding?
OnKure Therapeutics has 49.93M shares outstanding. The count is up 268.99% from a year earlier.
Does OKUR pay a dividend?
No. OnKure Therapeutics does not pay a dividend.
How much debt does OKUR have?
OnKure Therapeutics has $0 of total debt and $151.44M of cash and equivalents, a net cash position of $151.44M.
OKUR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors